Communicating the results of clinical research to participants: Attitudes, practices, and future directions

PLoS Medicine

Volumn 5, Issue 5, 2008, Pages 0714-0720

  Shalowitz, David I ^a   Miller, Franklin G ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATTITUDE; ATTITUDE TO ILLNESS; CANCER RESEARCH; CLINICAL PRACTICE; GENETICS; HEALTH CARE POLICY; HEALTH PERSONNEL ATTITUDE; HUMAN; INFORMATION RETRIEVAL; INTERPERSONAL COMMUNICATION; MEDICAL RESEARCH; OUTCOME VARIABLE; PATIENT PARTICIPATION; PRACTICE GUIDELINE; QUALITY CONTROL; REVIEW; SAMPLE SIZE; ARTICLE; ATTITUDE TO HEALTH; CLINICAL TRIAL (TOPIC); ETHICS; FEMALE; INSTITUTIONAL ETHICS; MALE; POLICY; PREGNANCY; PROFESSIONAL STANDARD; RESEARCH ETHICS;

ATTITUDE; BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; DISCLOSURE; ETHICS COMMITTEES, RESEARCH; ETHICS, INSTITUTIONAL; ETHICS, RESEARCH; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; ORGANIZATIONAL POLICY; PATIENT PARTICIPATION; PREGNANCY;

EID: 44449162023     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0050091     Document Type: Review

References (58)

1. Fernandez CV, Kodish E, Weijer C (2003) Informing study participants of research results: An ethical imperative. IRB 25: 12-9.
2. Shalowitz DI, Miller FG (2005) Disclosing individual results of clinical research: Implications of respect for participants. JAMA 294: 737-740.
3. Knoppers BM, Joly Y, Simard J, Durocher F (2006) The emergence of an ethical duty to disclose genetic research results: International perspectives. Eur J Hum Genet 14: 1170-1178.
4. Garcia J (1987) Sharing research results with patients: The views of caregivers involved in a randomized controlled trial. J Reprod Infant Psychol 5: 9-13.
5. Snowdon C, Garcia J, Elbourne D (1998) Reactions of participants to the results of a randomised controlled trial: Exploratory study. BMJ 317: 21-26.
6. Elbourne D (1987) Subjects' views about participation in a randomized controlled trial. J Reprod Infant Psychol 5: 3-8.
7. Ormondroyd E, Moynihan C, Watson M, Foster C, Davolls, S, et al. (2007) Disclosure of genetics research results after the death of the patient participant: A qualitative study of the impact on relatives. J Genet Couns 16: 527-538.
8. Dixon-Woods M, Jackson C, Windridge KC, Kenyon S (2006) Receiving a summary of the results of a trial: Qualitative study of participants' views. BMJ 332: 206-210.
9. Ormond KE, Smith ME, Cirino AL, Chisholm RL, Wolf WA (2004) "Duty" to recontact participants in a population based genetic database: The NUgene experience. American College of Medical Genetics Annual Conference; 6 March 2004; Kissimmee, Florida, United States.
10. Bunin GR, Kazak AE, Mitelman O (1996) Informing subjects of epidemiologic study results. Children's Cancer Group. Pediatrics 97: 486-491.
11. Richards MP, Ponder M, Pharoah P, Everest S, Mackay J (2003) Issues of consent and feedback in a genetic epidemiological study of women with breast cancer. J Med Ethics 29: 93-96.
12. Fernandez CV, Kodish E, Shurin S, Weijer C (2003) Offering to return results to research participants: Attitudes and needs of principal investigators in the Children's Oncology Group. J Pediatr Hematol Oncol 25: 704-708.
13. Fernandez CV, Kodish E, Taweel S, Shurin S, Weijer C (2003) Disclosure of the right of research participants to receive research results: An analysis of consent forms in the Children's Oncology Group. Cancer 97: 2904-2909.
14. Fernandez CV, Santor D, Weijer C, Strahlendorf C, Moghrabi, A, et al. (2007) The return of research results to participants: Pilot questionnaire of adolescents and parents of children with cancer. Pediatr Blood Cancer 48: 441-446.
15. Fernandez CV, Taweel S, Kodish E, Weijer C (2005) Disclosure of research results to research participants: A pilot study of the needs and attitudes of adolescents and parents. Paediatr Child Health 10: 332-334.
16. Partridge AH, Burstein HJ, Gelman RS, Marcom PK, Winer EP (2003) Do patients participating in clinical trials want to know study results? J Natl Cancer Inst 95: 491-492.
17. Partridge AH, Hackett N, Blood E, Gelman R, Joffe S, et al. (2004) Oncology physician and nurse practices and attitudes regarding offering clinical trial results to study participants. J Natl Cancer Inst 96: 629-632.
18. Partridge AH, Wong JS, Knudsen K, Gelman R, Sampson E, et al. (2005) Offering participants results of a clinical trial: Sharing results of a negative study. Lancet 365: 963-964.
19. Schulz CJ, Riddle MP, Valdimirsdottir HB, Abramson DH, Sklar CA (2003) Impact on survivors of retinoblastoma when informed of study results on risk of second cancers. Med Pediatr Oncol 41: 36-43.
20. Wendler D, Pentz R (2007) How does the collection of genetic test results affect research participants? Am J Med Genet A 143: 1733-1738.
21. Fong M, Braun KL, Chang RM (2004) Native Hawaiian preferences for informed consent and disclosure of results from research using stored biological specimens. Pac Health Dialog 11: 154-159.
22. Hoeyer K, Olofsson BO, Mjorndal T, Lynoe N (2004) Informed consent and biobanks: A population-based study of attitudes towards tissue donation for genetic research. Scand J Public Health 32: 224-229.
23. Moutel G, Duchange N, RaffiF, Sharara LI, Theodorou I, et al. (2005) Communication of pharmacogenetic research results to HIV-infected treated patients: Standpoints of professionals and patients. Eur J Hum Genet 13: 1055-1062.
24. Buchwald H, Fitch LL, Matts JP, Johnson JW, Hansen BJ, et al. (1993) Perception of quality of life before and after disclosure of trial results: A report from the Program on the Surgical Control of the Hyperlipidemias (POSCH). Control Clin Trials 14: 500-510.
25. Wendler D, Prasad K, Wilfond B (2002) Does the current consent process minimize the risks of genetics research? Am J Med Genet 113: 258-262.
26. Di Blasi Z, Kaptchuk TJ, Weinman J, Kleijnen J (2002) Informing participants of allocation to placebo at trial closure: Postal survey. BMJ 325: 1329.
27. Dinnett EM, Mungall MM, Gordon C, Ronald ES, Gaw A (2006) Offering results to research participants. BMJ 332: 549-550.
28. Dinnett EM, Mungall MM, Kent JA, Ronald ES, McIntyre KE, et al. (2005) Unblinding of trial participants to their treatment allocation: Lessons from the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER). Clin Trials 2: 254-259.
29. Macneil SD, Fernandez CV (2006) Informing research participants of research results: Analysis of Canadian university based research ethics board policies. J Med Ethics 32: 49-54.
30. MacNeil SD, Fernandez CV (2007) Attitudes of research ethics board chairs towards disclosure of research results to participants: Results of a national survey. J Med Ethics. 33: 549-553.
31. Rigby H, Fernandez CV (2005) Providing research results to study participants: Support versus practice of researchers presenting at the American Society of Hematology annual meeting. Blood 106: 1199-1202.
32. Wendler D, Emanuel E (2002) The debate over research on stored biological samples: What do sources think? Arch Intern Med 162: 1457-1462.
33. Bayer R (1986) Notifying workers at risk: The politics of the right-to-know. Am J Public Health 76: 1352-1356.
34. Schulte PA, Boal WL, Friedland JM, Walker JT, Connally LB, et al. (1993) Methodologic issues in risk communications to workers. Am J Ind Med 23: 3-9.
35. Ringen K (1989) The case for worker notification. Ann N Y Acad Sci 572: 133-141; discussion 142-143.
36. Wood FB (1990) Letter submitted to NIOSH by Westinghouse Electric Corporation as part of a panel of experts' analysis regarding interim report. HETA 89-116.
37. Hornsby JL, Sappington JT, Mongan P, Gullen WH, Bono SF,et al. (1985) Risk for bladder cancer. Psychological impact of notification. JAMA 253: 1899-1902.
38. Houts PS, McDougall V (1988) Effects of informing workers of their health risks from exposure to toxic materials. Am J Ind Med 13: 271-279.
39. Meyerowitz BE, Sullivan CD, Premeau CL (1989) Reactions of asbestos-exposed workers to notification and screening. Am J Ind Med 15: 463-475.
40. Mazzuckelli LF, Schulte PA (1993) Notification of workers about an excess of malignant melanoma: A case study. Am J Ind Med 23: 85-91.
41. Kumekawa ES, Lash AA, Becker CE (1992) Challenges of worker notification in neurotoxic studies of the central nervous system. Environ Res 59: 125-131.
42. Lash AA, Kumekawa ES, Becker CE (1993) Evaluating the clarity of research reports written for research subjects. Am J Ind Med 23: 211-219.
43. Meyerowitz BE (1993) Assessing quality of life when planning and evaluating worker notification programs: Two case examples. Am J Ind Med 23: 221-227.
44. Needleman C (1993) Social aspects of high-risk notification among chromium-exposed workers. Am J Ind Med 23: 113-123.
45. Needleman C (1993) Worker notification: Lessons from the past. Am J Ind Med 23: 11-23.
46. Rudolph L (1993) Issues in notification: Reflections of a public health worker. Am J Ind Med 23: 53-59.
47. Broadstock M, Michie S, Marteau T (2000) Psychological consequences of predictive genetic testing: A systematic review. Eur J Hum Genet 8: 731-738.
48. Lerman C, Croyle RT, Tercyak KP, Hamann H (2002) Genetic testing: Psychological aspects and implications. J Consult Clin Psychol 70: 784-797.
49. Smith CO, Lipe HP, Bird TD (2004) Impact of presymptomatic genetic testing for hereditary ataxia and neuromuscular disorders. Arch Neurol 61: 875-880.
50. Steinbart EJ, Smith CO, Poorkaj P, Bird TD (2001) Impact of DNA testing for early-onset familial Alzheimer disease and frontotemporal dementia. Arch Neurol 58: 1828-1831.
51. Dorval M, Gauthier G, Maunsell E, Dugas MJ, Rouleau I, et al. (2005) No evidence of false reassurance among women with an inconclusive BRCA1/2 genetic test result. Cancer Epidemiol Biomarkers Prev 14: 2862-2867.
52. Drossaert CH, Boer H, Seydel ER (2001) Does mammographic screening and a negative result affect attitudes towards future breast screening? J Med Screen 8: 204-212.
53. Marteau TM, Kinmonth AL, Thompson S, Pyke S (1996) The psychological impact of cardiovascular screening and intervention in primary care: A problem of false reassurance? British Family Heart Study Group. Br J Gen Pract 46: 577-582.
54. Marteau TM, Roberts S, LaRusse S, Green RC (2005) Predictive genetic testing for Alzheimer's disease: Impact upon risk perception. Risk Anal 25: 397-404.
55. van Dijk S, Otten W, Timmermans DR, van Asperen CJ, Meijers-Heijboer H, et al. (2005) What's the message? Interpretation of an uninformative BRCA1/2 test result for women at risk of familial breast cancer. Genet Med 7: 239-245.
56. Johnson KA, Trimbath JD, Petersen GM, Griffin CA, Giardiello FM (2002) Impact of genetic counseling and testing on colorectal cancer screening behavior. Genet Test 6: 303-306.
57. Lerman C, Marshall J, Audrain J, Gomez-Caminero A (1996) Genetic testing for colon cancer susceptibility: Anticipated reactions of patients and challenges to providers. Int J Cancer 69: 58-61.
58. Clausen H, Brandt NJ, Schwartz M, Flemming S (1996) Psychological impact of carrier screening for cystic fibrosis among pregnant women. Eur J Hum Genet 4: 120-123.